Literature DB >> 3122638

[Modification of intestinal colonization and translocation of Campylobacter jejuni by erythromycin and an extract of Lactobacillus acidophilus in axenic mice].

E N Moyen1, F Bonneville, J L Fauchère.   

Abstract

Erythromycin (15 mg) or lyophylized heat-killed Lactobacillus acidophilus (80 mg) were administered per os daily in germ-free mice infected at day O with 10(7)-10(8) Campylobacter jejuni per os. Bacterial colonization of intestine and bacterial translocation of C. jejuni toward mesenteric lymph nodes, blood and liver were then studied for 5 days. The results were compared with those from an infected untreated control group. Compared to the control group, the numbers of free and mucosa-associated bacteria decreased at day 5 in the erythromycin-treated group and the number of mucosa-associated bacteria was reduced from day 1 to day 5 in the Lactobacillus-treated group. Both treatments reduced the frequency of bacterial translocation toward mesenteric lymph nodes from day 1 to day 5. We concluded that both erythromycin and heat-killed L. acidophilus are effective in treating Campylobacter infection in mice, though probably through different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3122638     DOI: 10.1016/s0769-2609(86)80024-2

Source DB:  PubMed          Journal:  Ann Inst Pasteur Microbiol (1985)


  9 in total

1.  Comparative translocation of enteropathogenic Campylobacter spp. and Escherichia coli from the intestinal tract of gnotobiotic mice.

Authors:  M Youssef; G Corthier; H Goossens; C Tancrede; M Henry-Amar; A Andremont
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

2.  Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB.

Authors:  M H Coconnier; V Liévin; M F Bernet-Camard; S Hudault; A L Servin
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.

Authors:  M F Bernet-Camard; V Liévin; D Brassart; J R Neeser; A L Servin; S Hudault
Journal:  Appl Environ Microbiol       Date:  1997-07       Impact factor: 4.792

4.  Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.

Authors:  V Liévin; I Peiffer; S Hudault; F Rochat; D Brassart; J R Neeser; A L Servin
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

5.  Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB.

Authors:  M H Coconnier; V Lievin; E Hemery; A L Servin
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

Review 6.  A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB.

Authors:  Vanessa Liévin-Le Moal
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

7.  Micronutrients (including zinc) reduce diarrhoea in children: the Pakistan Sprinkles Diarrhoea Study.

Authors:  W Sharieff; Z Bhutta; C Schauer; G Tomlinson; S Zlotkin
Journal:  Arch Dis Child       Date:  2006-03-23       Impact factor: 3.791

Review 8.  Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  Lactobacillus johnsonii ameliorates intestinal, extra-intestinal and systemic pro-inflammatory immune responses following murine Campylobacter jejuni infection.

Authors:  Stefan Bereswill; Ira Ekmekciu; Ulrike Escher; Ulrike Fiebiger; Kerstin Stingl; Markus M Heimesaat
Journal:  Sci Rep       Date:  2017-05-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.